These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14584723)

  • 1. A group sequential approach to evaluation of bridging studies.
    Hsiao CF; Xu JZ; Liu JP
    J Biopharm Stat; 2003 Nov; 13(4):793-801. PubMed ID: 14584723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of prior information for Bayesian evaluation of bridging studies.
    Hsiao CF; Hsu YY; Tsou HH; Liu JP
    J Biopharm Stat; 2007; 17(1):109-21. PubMed ID: 17219758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bayesian noninferiority approach to evaluation of bridging studies.
    Liu JP; Hsueh H; Hsiao CF
    J Biopharm Stat; 2004 May; 14(2):291-300. PubMed ID: 15206527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A consistency approach to evaluation of bridging studies and multi-regional trials.
    Tsou HH; Chien TY; Liu JP; Hsiao CF
    Stat Med; 2011 Jul; 30(17):2171-86. PubMed ID: 21590701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-stage design for bridging studies.
    Hsiao CF; Xu JZ; Liu JP
    J Biopharm Stat; 2005; 15(1):75-83. PubMed ID: 15702606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size determination for a specific region in a multiregional trial.
    Ko FS; Tsou HH; Liu JP; Hsiao CF
    J Biopharm Stat; 2010 Jul; 20(4):870-85. PubMed ID: 20496211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian approach to evaluation of bridging studies.
    Liu JP; Hsiao CF; Hsueh H
    J Biopharm Stat; 2002 Aug; 12(3):401-8. PubMed ID: 12448580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weighted evidence approach of bridging study.
    Tsou HH; Tsong Y; Liu JT; Dong X; Wu Y
    J Biopharm Stat; 2012 Sep; 22(5):952-65. PubMed ID: 22946942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical methods for bridging studies.
    Chow SC; Chiang C; Liu JP; Hsiao CF
    J Biopharm Stat; 2012 Sep; 22(5):903-15. PubMed ID: 22946939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridging bioequivalence studies.
    Liu JP
    J Biopharm Stat; 2004 Nov; 14(4):857-67. PubMed ID: 15587968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive group sequential test for clinical trials with changing patient population.
    Feng H; Shao J; Chow SC
    J Biopharm Stat; 2007; 17(6):1227-38. PubMed ID: 18027228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical concepts in the planning and evaluation of drug safety from clinical trials in drug development: issues of international harmonization.
    O'Neill RT
    Stat Med; 1995 May 15-30; 14(9-10):117-27. PubMed ID: 7569506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging studies in clinical development.
    Liu JP; Chow SC
    J Biopharm Stat; 2002 Aug; 12(3):359-67. PubMed ID: 12448577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A predictive Bayesian approach to the design and analysis of bridging studies.
    Gould AL; Jin T; Zhang LX; Wang WW
    J Biopharm Stat; 2012 Sep; 22(5):916-34. PubMed ID: 22946940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size allocation to regions in a multiregional trial.
    Uesaka H
    J Biopharm Stat; 2009 Jul; 19(4):580-94. PubMed ID: 20183427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for including patients recruited during interim analysis of clinical trials.
    Faldum A; Hommel G
    J Biopharm Stat; 2007; 17(6):1211-25. PubMed ID: 18027227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [International collaborative trial: from the viewpoints of statistics and data management].
    Ohashi Y
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):312-5. PubMed ID: 17301552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteriation of clinical data packages using foreign data in new drug applications in Japan.
    Tanaka M; Nagata T
    Clin Pharmacol Ther; 2008 Sep; 84(3):340-6. PubMed ID: 17786162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phased approach to clinical testing: criteria for progressing from Phase I to Phase II to Phase III studies.
    André FE; Foulkes MA
    Dev Biol Stand; 1998; 95():57-60. PubMed ID: 9855414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues on the selection of non-inferiority margin in clinical trials.
    Hou Y; Wu XY; Li K
    Chin Med J (Engl); 2009 Feb; 122(4):466-70. PubMed ID: 19302756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.